英特集团跌3.65%，成交额6809.69万元，主力资金净流出333.77万元

Group 1 - The core viewpoint of the news is that Int Group's stock has experienced fluctuations, with a recent decline of 3.65% and a year-to-date increase of 20.68% [1] - As of December 19, 2025, Int Group reported a revenue of 24.963 billion yuan, reflecting a year-on-year growth of 0.75%, while the net profit attributable to shareholders decreased by 9.15% to 323 million yuan [2] - The company has distributed a total of 532 million yuan in dividends since its A-share listing, with 423 million yuan distributed in the last three years [3] Group 2 - Int Group's main business involves wholesale and retail of pharmaceuticals and medical devices, with pharmaceutical sales accounting for 93.76% of total revenue [1] - The company has seen an increase in the number of shareholders, reaching 25,700, which is a 10.24% increase from the previous period [2] - As of September 30, 2025, Hong Kong Central Clearing Limited is the sixth-largest circulating shareholder, holding 1.8963 million shares, an increase of 190,400 shares from the previous period [3]